Researchers continue to excited about the medication , a groundbreaking dual treatment showing promising data in early trials for size reduction . It acts by impacting two pathways : GLP-1 and GIP, https://deweytjgq061037.glifeblog.com/39456798/a-new-hope-for-body-loss